Literature DB >> 28091866

Review of Diagnostic Challenges in Occupational Asthma.

Jacques A Pralong1,2, Andre Cartier3.   

Abstract

PURPOSE OF REVIEW: Occupational asthma (OA) is one of the most frequent occupational diseases and its diagnosis is often difficult. This review summarizes its current diagnostic challenges. RECENT
FINDINGS: OA is associated with significant health and socio-economic burden. It is underdiagnosed and physicians need to adopt a stepwise approach to confirm the diagnosis. Although early removal from exposure to the offending agent is associated with a better prognosis, physicians should try to confirm the diagnosis of work-related asthma before taking a worker off work. A proper occupational and medical history is very important but is not enough to make the diagnosis of OA. Objective evidence of work-related asthma is required and this represents a serious challenge to most physicians. Measurement of non-specific bronchial responsiveness (NSBR) and spirometry may confirm the diagnosis of asthma but do not confirm the diagnosis of OA. Serial monitoring of peak expiratory flows (PEF), NSBR, and airway inflammation at and off work may confirm the diagnosis of OA but are often difficult to perform. Confirming sensitization by skin prick tests or specific IgE may help to support the diagnosis of OA. Specific inhalation challenges (SIC) in the lab or at work are considered the reference standard but are of limited access. Medical surveillance programs along with primary prevention (reducing exposure) may help to reduce the burden of OA, but the ideal program has yet to be defined. The diagnostic workup of OA remains a challenge and needs a rigorous stepwise evaluation.

Entities:  

Keywords:  Monitoring; Occupational asthma; Peak expiratory flow; Specific inhalation challenges

Mesh:

Year:  2017        PMID: 28091866     DOI: 10.1007/s11882-017-0676-3

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  61 in total

1.  Interpretation of occupational peak flow records: level of agreement between expert clinicians and Oasys-2.

Authors:  D R Baldwin; P Gannon; P Bright; D T Newton; A Robertson; K Venables; B Graneek; R D Barker; A Cartier; J-L Malo; M Wilsher; C F A Pantin; P S Burge
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

2.  An effective strategy for diagnosing occupational asthma: use of induced sputum.

Authors:  Frédéric Girard; Simone Chaboillez; André Cartier; Johanne Côté; Frederick E Hargreave; Manon Labrecque; Jean-Luc Malo; Susan M Tarlo; Catherine Lemière
Journal:  Am J Respir Crit Care Med       Date:  2004-07-21       Impact factor: 21.405

3.  Relationship between chemical structure and the occupational asthma hazard of low molecular weight organic compounds.

Authors:  J Jarvis; M J Seed; R Elton; L Sawyer; R Agius
Journal:  Occup Environ Med       Date:  2005-04       Impact factor: 4.402

4.  Barriers to the recognition and reporting of occupational asthma by Canadian pulmonologists.

Authors:  Anu Parhar; Catherine Lemiere; Jeremy R Beach
Journal:  Can Respir J       Date:  2011 Mar-Apr       Impact factor: 2.409

5.  Specific inhalation challenge in the diagnosis of occupational asthma: consensus statement.

Authors:  Olivier Vandenplas; Hille Suojalehto; Tor B Aasen; Xaver Baur; P Sherwood Burge; Frederic de Blay; David Fishwick; Jennifer Hoyle; Piero Maestrelli; Xavier Muñoz; Gianna Moscato; Joaquin Sastre; Torben Sigsgaard; Katri Suuronen; Jolanta Walusiak-Skorupa; Paul Cullinan
Journal:  Eur Respir J       Date:  2014-03-06       Impact factor: 16.671

6.  Serial measurements of exhaled nitric oxide at work and at home: a new tool for the diagnosis of occupational asthma.

Authors:  Rolf Merget; Ingrid Sander; Vera van Kampen; Monika Raulf-Heimsoth; Olaf Hagemeyer; Eike Marek; Thomas Brüning
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

7.  The use of a work-related asthma screening questionnaire in a primary care asthma program: an intervention trial.

Authors:  Katie R Killorn; Suzanne M Dostaler; Patti A Groome; M Diane Lougheed
Journal:  J Asthma       Date:  2014-10-30       Impact factor: 2.515

8.  A workers' compensation claim population for occupational asthma. Comparison of subgroups.

Authors:  S M Tarlo; G Liss; P Corey; I Broder
Journal:  Chest       Date:  1995-03       Impact factor: 9.410

9.  Screening for occupational asthma by using a self-administered questionnaire in a clinical setting.

Authors:  Jacques A Pralong; Gregory Moullec; Eva Suarthana; Michel Gérin; Denyse Gautrin; Jocelyne Lʼ Archevêque; Manon Labrecque
Journal:  J Occup Environ Med       Date:  2013-05       Impact factor: 2.162

10.  Comparison between Airway Responses to High versus Low Molecular Weight Compounds in Occupational Asthma.

Authors:  D Talini; F Novelli; E Bacci; F L Dente; M De Santis; A Di Franco; L Melosini; B Vagaggini; P L Paggiaro
Journal:  J Allergy (Cairo)       Date:  2011-05-25
View more
  4 in total

1.  An increase of fractional exhaled nitric oxide after specific inhalation challenge is highly predictive of occupational asthma.

Authors:  Julia Engel; Vera van Kampen; Anne Lotz; Jessica Abramowski; Vitali Gering; Olaf Hagemeyer; Thomas Brüning; Monika Raulf; Rolf Merget
Journal:  Int Arch Occup Environ Health       Date:  2018-05-30       Impact factor: 3.015

Review 2.  Work-related asthma.

Authors:  Lavinia Clara Del Roio; Rafael Futoshi Mizutani; Regina Carvalho Pinto; Mário Terra-Filho; Ubiratan Paula Santos
Journal:  J Bras Pneumol       Date:  2021-08-11       Impact factor: 2.624

3.  Reducing PM10 and PM2.5 Concentrations in a Subway Station by Changing the Diffuser Arrangement.

Authors:  Seong-Gyu Kim; Gibong Sung; Se-Jin Yook; Minjeong Kim; Duckshin Park
Journal:  Toxics       Date:  2022-09-15

Review 4.  Chikungunya, Dengue, and Zika in Immunocompromised Hosts.

Authors:  Luiz Guilherme Darrigo; Alexandre Machado de Sant'Anna Carvalho; Clarisse Martins Machado
Journal:  Curr Infect Dis Rep       Date:  2018-03-17       Impact factor: 3.725

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.